FDA Variance Approval Letter to Kyle Cummings

The Food and Drug Administration (FDA) has issued a variance approval letter to an individual named Kyle Cummings. The document, posted on March 20, 2026, is designated as restricted due to the presence of personally identifiable information. The Center for Devices and Radiological Health (CDRH) is listed as the author.

This notice serves as an official record of the FDA's decision regarding a variance request. While the specific nature of the variance and its implications are not detailed due to redactions, regulated entities, particularly drug and medical device manufacturers, should be aware of such approvals as they may set precedents or indicate specific pathways for regulatory compliance. No immediate actions are required for general compliance officers, but awareness of this approval is noted.